FATE THERAPEUTICS INC — Director's Dealing 2016

Jan 12, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FATE THERAPEUTICS INC (FATE)
CIK: 0001434316
Period of Report: 2016-01-08

Reporting Person: Shoemaker Daniel D (Chief Scientific Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-01-08	Common Stock	A	9388	$0.00	Acquired	103816	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-01-08	Stock Option (right to buy)	$2.90	A	148800	Acquired	2026-01-07	Common Stock (148800)	Direct

Footnotes

F1: Represents shares issued pursuant to the Company's 2013 Stock Option and Incentive Plan as a portion of a bonus earned by the reporting person for the fiscal year ended December 31, 2015.

F2: The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning on February 8, 2016 such that this option is fully exercisable on January 8, 2020.

F3: Not applicable.